Navigation Links
HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
Date:1/19/2012

LOS ALTOS HILLS, Calif., Jan. 19, 2012 /PRNewswire/ -- HealthTech Capital announced today that it invested over $300,000 as the lead Series A2 investor in Cadence Biomedical, Inc. The move underscores the growing trend of angel investor groups joining forces to fund innovative, early-stage companies. Other investors included Alliance of Angels, Frontier Angels, Keiretsu Forum Northwest, Sand Hill Angels, and Wings. With a first close of ~$750,000 in new funds and note conversions, additional investors are expected to push the total to $1 million or more.

The funding supports the market launch of Cadence's novel device that helps people with severe disabilities walk. Worn externally, the device provides stability and movement assistance to weakened muscles without the use of powered mechanisms.

"With healthcare costs continuing their relentless march upward, creative technologies that decrease costs while improving patient care are attractive investment opportunities," said Don Ross, cofounder and managing director of HealthTech Capital. "Cadence is well positioned in the emerging HealthTech sector, and we are delighted to support such innovation with both investment dollars and hands-on mentoring."

"We are pleased to have HealthTech Capital as our lead investor," said Brian Glaister, Chief Executive Officer of Cadence. "Their domain expertise and professionalism are exceptional. They have worked with us and provide great added-value beyond their investment. With their lead, we are receiving the funding we need to bring our products to market."

"Cadence has the potential to change people's lives. When I tried the prototype, I could walk better immediately," said Donna Jang, Cadence Board Director and HealthTech Capital investor. "The experience was unlike any other in the 20 years since my stroke."

The Cadence device amplifies muscle strength, helping to propel the user forward and lift the leg and foot in preparation for the next step. Not only does it improve walking, it also has the potential to enable many who would otherwise require wheelchairs to regain strength and coordination.

About HealthTech Capital
HealthTech Capital is a leading Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market where innovation improves healthcare delivery, empowers patients, and lowers costs. Founded by Anne DeGheest, Kathy La Porte, and Don Ross, HealthTech Capital has built a membership of industry leaders – successful entrepreneurs, executives, physicians, and venture capitalists – who fund and mentor new companies. For more information, please visit www.HealthTechCapital.com.

About Cadence Biomedical
Cadence Biomedical is a privately held early stage medical device company whose mission is to improve mobility for people with disabilities. The company's flagship kinetic orthosis product is a revolutionary device that can provide assistance to muscles and help people with severe disabilities walk. Cadence is headquartered in Seattle, WA. For more information, please visit www.cadencebiomedical.com.


'/>"/>
SOURCE HealthTech Capital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmaSecure, an Innovator in Pharmaceutical Serialization, Closes $3.9M Investment by Eric Schmidts Innovation Endeavors, Gray Ghost Ventures, Healthtech Capital and the TEEC Angel Fund
2. HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market
3. Cempra Pharmaceuticals to Present at Two Upcoming Cambridge Healthtech Institute (CHI) Conferences
4. Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets Eighth Annual Equity Conference
5. MiMedx Group, Inc. to Present at the Noble Capital Markets 8th Annual Equity Conference
6. Avista Capital Partners Agrees to Sell BioReliance to Sigma-Aldrich Corporation
7. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
8. Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P.
9. Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
10. IsZo Capital Writes to Taro Pharmaceutical Board Commenting on Management Proposals for 2011 Annual Shareholder Meeting; Reflecting on Sun Pharmas Response to Similar 2009 Proposals
11. IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Pa. , Dec. 5, 2016  Pennsylvania Physician ... Drug and Alcohol Programs Gary Tennis today ... drug, at Minnich,s Pharmacy in York ... order signed by Dr. Levine as a prescription to ... "It,s important to remember that any Pennsylvanian ...
(Date:12/5/2016)... India , December 5, 2016 According ... by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free ... published by MarketsandMarkets, the market is projected to reach USD 779.8 ... a CAGR of 13.5% during the forecast period of 2016 to ... ...
(Date:12/5/2016)... Sanovas, Inc., a life science asset holding company ... wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed Intubation ... http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed annually ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... The V Foundation for Cancer ... a Moment to Lose fundraising campaign. As the V Foundation’s boldest initiative to ... over cancer. The campaign aims to raise $200 million by 2020 and strategically ...
(Date:12/6/2016)... ... December 06, 2016 , ... Just in time for the holiday ... chocolate chip cookie recipe for Honeyville’s new Organic Quinoa Flour product for sale at ... in the near future. , “I think it’s wonderful that a growing number ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind ... design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... recount of a powerful woman's story of sacrifice and enlightenment. , ... published author, Carolyn Fryer. Always looking for creative outlets, Carolyn gravitated toward writing ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... only authorized OSHA Training Institute Education Center headquartered in Northern California, has announced ... on providing occupational safety and health training to public sector employees. , “The ...
Breaking Medicine News(10 mins):